Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies

Ítems similars

• Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
  per: Frontiers Production Office
  Publicat: (2024-01-01)
• Antimicrobial Efficacy of Cefoperazone-Salbactam Plus Tigecycline versus Cefoperazone-Salbactam Against Respiratory Pathogens and Their Effect on Laboratory Indices
  per: Sundas Shaukat, et al.
  Publicat: (2023-07-01)
• Risk Factors for Cefoperazone/Sulbactam-Induced Coagulation Disorder
  per: Miao W, et al.
  Publicat: (2023-09-01)
• Coagulopathy Induced by Cefoperazone/Sulbactam in a Geriatric Patient
  per: Ergenekon Karagoz, et al.
  Publicat: (2015-12-01)
• The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model
  per: Changjing Xu, et al.
  Publicat: (2025-01-01)